Human MIP synthase splice variants in bipolar disorder

Bipolar Disorders

Volumn 9, Issue 7, 2007, Pages 766-771

  Shamir, Alon ^a   Shaltiel, Galit ^a   Mark, Shirly ^a   Bersudsky, Yuly ^a   Belmaker, Robert H ^a   Agam, Galila ^a,b  

^a MENTAL HEALTH CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Alternative splicing; Bipolar disorder; Gene expression; Inositol; Mood stabilizers; Myo inositol 1 phosphate synthase

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; HALOPERIDOL; LITHIUM; MYOINOSITOL 1 PHOSPHATE SYNTHASE; OLANZAPINE; OMEGA 3 FATTY ACID; PENFLURIDOL; RISPERIDONE; VALPROIC ACID;

ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; EXON; FAMILY HISTORY; FEMALE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; MALE; MENTAL DISEASE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; RNA PURIFICATION; RNA SPLICING;

ADULT; ALTERNATIVE SPLICING; BIPOLAR DISORDER; EXONS; FRONTAL LOBE; GENE EXPRESSION; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MYO-INOSITOL-1-PHOSPHATE SYNTHASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VARIATION (GENETICS);

EID: 35748954351     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2007.00440.x     Document Type: Article

References (30)

1. Xu Q, Modrek B, Lee C. Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. Nucleic Acids Res 2002; 30: 3754-3766.
2. D'Sa C, Eisch AJ, Bolger GB, Duman RS. Differential expression and regulation of the cAMP-selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration. Eur J Neurosci 2005;22: 1463-1475.
3. Johnson JM, Castle J, Garrett-Engele P et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 2003; 302: 2141-2144.
4. Stamm S, Ben-Ari S, Rafalska I et al. Function of alternative splicing. Gene 2005;344: 1-20.
5. Philips AV, Cooper TA. RNA processing and human disease. Cell Mol Life Sci 2000;57: 235-249.
6. Clinton SM, Haroutunian V, Davis KL, Meador-Woodruff JH. Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia. Am J Psychiatry 2003;160: 1100-1109.
7. Dracheva S, Elhakem SL, Marcus SM, Siever LJ, McGurk SR, Haroutunian V. RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia. J Neurochem 2003;87: 1402-1412.
8. Nudmamud-Thanoi S, Reynolds GP. The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders. Neurosci Lett 2004; 372: 173-177.
9. Smith MJ, Sharples RA, Evin G et al. Expression of truncated presenilin 2 splice variant in Alzheimer's disease, bipolar disorder, and schizophrenia brain cortex. Brain Res Mol Brain Res 2004; 127: 128-135.
10. Shaltiel G, Shamir A, Shapiro J et al. Valproate decreases inositol biosynthesis. Biol Psychiatry 2004; 56: 868-874.
11. O'Donnell T, Rotzinger S, Nakashima TT, Hanstock CC, Ulrich M, Silverstone PH. Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain. Brain Res 2000; 880: 84-91.
12. Vaden DL, Ding D, Peterson B, Greenberg ML. Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis. J Biol Chem 2001;276: 15466-15471.
13. Hallcher LM, Sherman WR. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem 1980; 255: 10896-10901.
14. Ju S, Shaltiel G, Shamir A, Agam G, Greenberg ML. Human 1-D-myo-inositol-3-phosphate synthase is functional in yeast. J Biol Chem 2004; 279: 21759-21765.
15. Frazer KA, Pachter L, Poliakov A, Rubin EM, Dubchak I. VISTA: computational tools for comparative genomics. Nucleic Acids Res 2004; 32 (Web Server issue): W273-W279.
16. Mayor C, Brudno M, Schwartz JR et al. VISTA: Visualizing global DNA sequence alignments of arbitrary length. Bioinformatics 2000; 16: 1046-1047.
17. Gross-Isseroff R, Salama D, Israeli M, Biegon A. Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem: Effect of suicide. Brain Res 1990; 507: 208-215.
18. Shaltiel G, Shamir A, Levi I, Bersudsky Y, Agam G. Lymphocyte G-protein receptor kinase (GRK)3 mRNA levels in bipolar disorder. Int J Neuropsychopharmacol 2006;9: 761-766.
19. Shamir A, Shaltiel G, Greenberg ML, Belmaker RH, Agam G. The effect of lithium on expression of genes for inositol biosynthetic enzymes in mouse hippocampus: A comparison with the yeast model. Brain Res Mol Brain Res 2003;115: 104-110.
20. Brett D, Pospisil H, Valcarcel J, Reich J, Bork P. Alternative splicing and genome complexity. Nat Genet 2002; 30: 29-30.
21. Pruunsild P, Timmusk T. Structure, alternative splicing, and expression of the human and mouse KCNIP gene family. Genomics 2005; 86: 581-593.
22. Matlin AJ, Clark F, Smith CW. Understanding alternative splicing: towards a cellular code. Nat Rev Mol Cell Biol 2005;6: 386-398.
23. Black DL. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 2003; 72: 291-336.
24. Ule J, Jensen KB, Ruggiu M, Mele A, Ule A, Darnell RB. CLIP identifies Nova-regulated RNA networks in the brain. Science 2003; 302: 1212-1215.
25. Ule J, Ule A, Spencer J et al. Nova regulates brain-specific splicing to shape the synapse. Nat Genet 2005; 37: 844-852.
26. Lewis BP, Green RE, Brenner SE. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci USA 2003; 100: 189-192.
27. Labow BI, Souba WW, Abcouwer SF. Mechanisms governing the expression of the enzymes of glutamine metabolism -glutaminase and glutamine synthetase. J Nutr 2001; 131 (Suppl. 9): 2467-2474; discussion 2486-2487.
28. Jones RB, Wang F, Luo Y et al. The nonsense-mediated decay pathway and mutually exclusive expression of alternatively spliced FGFR2IIIb and - IIIc mRNAs. J Biol Chem 2001;276: 4158-4167.
29. Warsh J, Young L, Li P. Guanine nucleotide binding (G) protein disturbances in bipolar disorders affective disorder. In: Manji H, Bowden C, Belmaker R eds. Mechanisms of Action of Antibipolar Drugs: Focus on Lithium, Carbamazepine and Valporic Acid. Washington: American Psychiatric Association Press, Inc., 2000: 299-319.
30. Mann JJ, Brent DA, Arango V. The neurobiology and genetics of suicide and attempted suicide: A focus on the serotonergic system. Neuropsychopharmacology 2001;24: 467-477.